The structure of lipopolysaccharide transport protein B (LptB) from Burkholderia pseudomallei by Pankov, G. et al.
                                                                    
University of Dundee
The structure of lipopolysaccharide transport protein B (LptB) from Burkholderia
pseudomallei
Pankov, G.; Dawson, A.; Hunter, W. N.
Published in:







Link to publication in Discovery Research Portal
Citation for published version (APA):
Pankov, G., Dawson, A., & Hunter, W. N. (2019). The structure of lipopolysaccharide transport protein B (LptB)
from Burkholderia pseudomallei. Acta Crystallographica Section F: Structural Biology Communications, 75(4),
227-232. https://doi.org/10.1107/S2053230X19001778
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 24. Nov. 2019
 Communication 
 
The structure of lipopolysaccharide transport protein B (LptB) from 
Burkholderia pseudomallei. 
 
Genady Pankov, Alice Dawson and William N. Hunter 
 
Division of Biological Chemistry & Drug Discovery, School of Life Sciences, 
University of Dundee, Dundee DD1 5EH, Scotland, UK 
 




PDB reference: 6HS3 
 
Synopsis 
The structure of a lipopolysaccharide transport protein B (LptB) is reported. 
Comparisons with LptB from different bacterial species reveal that the dimeric 
assembly is independent of interaction with the rest of the transport machinery and 









The thick outer membrane (OM) of Gram-negative bacteria performs an important 
protective role against hostile environments, supports cell integrity, contributes to 
surface adhesion and in some cases also to virulence. A major component of the OM is 
lipopolysaccharide (LPS), a complex glycolipid attached to a core containing fatty acyl 
chains. The assembly and transport of lipid A, the membrane anchor for LPS, to the 
OM begins when a heteromeric LptB2FG protein complex extracts lipid A from the 
outer leaflet of the inner membrane. This process requires energy and one component 
of a heteromeric assembly, LptB, upon hydrolysis of ATP, triggers a conformational 
change in LptFG in support of lipid A transport. We report a structure of LptB from 
the intracellular pathogen Burkholderia pseudomallei. LptB forms a dimer that 
displays a relatively fixed structure irrespective of whether in complex with LptFG or 
in isolation. We discuss highly conserved sequence and structural features that allow 
LptB to fuel the transport of lipid A. 
   
 1. Introduction 
Gram-negative bacteria possess a cell wall with double membrane architecture. This 
protective barrier comprises an inner membrane (IM), the periplasm, which contains a 
mesh of linked sugars and amino acids, and an outer membrane (OM) with an inner 
phospholipid layer and outer lipopolysaccharide (LPS) shield (Clifton et al., 2013). 
LPS consists of lipid A and oligosaccharides (Rietschel et al., 1994). Disruption of 
LPS integrity sensitizes bacteria to antibiotics (e.g. aminoglycosides) as well as to the 
host immune response and can render the bacteria non-virulent (Delcour, 2009; 
Tsujimoto, Gotoh & Nishino, 1999; Chapman & Georgopapadakou, 1998). On that 
basis therefore the proteins that contribute to LPS biosynthesis and OM assembly 
represent potential targets for antibacterial drug development. 
The assembly of components that form the asymmetric IM/OM bilayer requires 
coordinated synthesis and transport across the periplasm. This process is tightly 
regulated since the correct assembly of LPS is crucial for the survival of the cell. A 
lipopolysaccharide transport complex (LPT) of at least seven proteins (Putker, Bos & 
Tommassen, 2015; Sperandeo et al., 2010) is required for export to the OM but the 
mechanistic details of this process are not completely understood. Transport of LPS 
begins at the IM where the heterodimeric complex of membrane-bound LptF-LptG 
proteins act in conjunction with the nucleotide-binding lipopolysaccharide transport 
protein B (LptB) to form a transmembrane ATP-binding cassette transporter (Narita & 
Tokuda, 2009; Sherman et al., 2014; Sperandeo et al., 2010). The transport of LPS 
requires energy and LptB is thought to bind to the transmembrane LptFG complex, on 
the cytosolic side, hydrolyse ATP and subsequently trigger a conformational change 
that supports relocation of LPS through the periplasm. 
We are engaged in structural studies to inform on the biosynthesis of different 
components (Buetow et al., 2007; Ulaganathan et al., 2007), the organisation and 
function of the multiprotein complexes involved in LPS assembly and transport. The 
reagents and models we generate can inform the search for molecules that will 
compromise OM integrity in bacteria and therefore may have potential in early-stage 
antibiotic drug discovery (Hunter, 2007). We report a 2.4 Å resolution structure of 
LptB from the intracellular aerobic pathogen Burkholderia pseudomallei, which is the 
causative agent of melioidosis. This is a particularly difficult to treat infection 
widespread in tropical regions (Wiersinga et al., 2012). Structural features of the 
cytosolic LptB (BpLptB) will be discussed, and comparisons to close orthologs in 
 isolation and when bound to LptFG presented. 
 
2. Materials and methods 
The gene encoding B. pseudomallei LptB, optimized for expression in Escherichia 
coli, (GenScript) was sub-cloned into the expression vector, pET15b-TEV (modified 
from pET15b, Novagen).  The resulting plasmid produces protein with an N-terminal 
hexa-histidine tag that is cleavable by tobacco etch virus (TEV) protease. The plasmid 
was heat-shock transformed into E. coli BL21 (DE3) for production of recombinant 
protein.  Typically, bacteria were cultured at 310 K to an optical density at 600 nm of 
0.5-0.6 in Luria-Bertani media containing 50 mg L-1 carbenicillin. Gene expression 
was induced with isopropyl ß-D-1-thiogalactopyranoside (final concentration 1 mM) 
and growth of the culture continued for approximately 16 h at 296 K prior to 
harvesting the cells by centrifugation (3500 g for 25 minutes at 277 K). Cells were 
lysed using a French press at 30 kpsi and the lysate clarified by centrifugation at 
37,500 g for 30 min at 277 K.  The supernatant was filtered (0.2 µm) and loaded onto a 
5 mL HisTrap HP column (GE Healthcare) previously charged with Ni2+, for an initial 
affinity chromatography step. The target protein was eluted between 460 and 520 mM 
imidazole, fractions containing BpLptB pooled and treated with TEV protease (1 mg of 
protease per 10 mg protein) at 296 K for 3 h. Dialysis at room temperature, to remove 
excess imidazole, was followed by reverse affinity chromatography on the HisTrap 
column, prior to a final purification step by size exclusion chromatography using a 
calibrated Superdex [200] 16/60 gel filtration column (GE Healthcare) in 50 mM 
HEPES-NaOH pH 7.5, 250 mM NaCl, 5 mM MgCl2, 10% glycerol and 500 μM ATP. 
Initial attempts at purification gave rise to heavy precipitation and loss of material 
during dialysis. The addition of ATP to the buffer alleviated these solubility issues.  
The theoretical mass of BpLptB is approximately 28 kDa and in size exclusion 
chromatography a well-defined profile suggested the presence of a single species of 
approximate molecular mass 42 kDa. Fractions containing LptB were pooled and 
exchanged into 50 mM Tris-HCl, 150 mM NaCl pH 7.5, 5 mM MgCl2 and 500 μM 
ATP and concentrated using centrifugal force (Sartorius) prior to crystallisation trials. 
Sample purity was assessed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis. The approximate yield of BpLptB was 1.6 mg L-1 of E. coli. 
 
 2.2. Crystallisation 
 
A search for crystallisation conditions was initiated using commercially available 
screens and identified a starting point that was optimized. BpLptB gave crystals in 
sitting-drop vapour-diffusion experiments when 2 μL of a protein solution at 4 mg mL-
1 in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM ATP, 5 mM MgCl2 was mixed 
with an equal volume of reservoir (0.2 M MgCl2, 0.1M Tris-HCl pH 8.5 and 30% w/v 
PEG4000). Needle-shaped crystals, typically with dimensions of 15 x 15 x 800 µm, 
appeared over 5 days at 296 K.  
2.3. X-ray data collection and processing, structure determination and refinement 
 
Crystals were cryo-protected in mother liquor supplemented with 10 % (v/v) ethylene 
glycol, then flash cooled in liquid nitrogen prior to shipment to the Diamond Light 
Source synchrotron facility (Harwell Science and Innovation Campus, Oxfordshire). 
Diffraction data were subsequently collected using a micro-focused beamline I24, λ = 
0.9686 Å, and Pilatus3 6M detector.  
Data to 2.4 Å were integrated using MOSFLM (Battye et al., 2011) then 
processed with AIMLESS (Evans, 2011). Pronounced radiation damage was noted and 
influenced which data were included in the refinement. A single polypeptide from 
Paraburkholderia phymatum LptB (PDB code 4WBS) with 90% sequence identity 
provided a model for molecular replacement calculations in PhaserMR (McCoy et al., 
2007). Two such polypeptides were positioned in the unit cell and the resulting 
electron density map allowed the BpLptB sequence to be incorporated using COOT 
(Emsley et al., 2010) with refinement in REFMAC5 (Murshudov et al., 2011). Weak 
non-crystallographic symmetry restraints were employed during refinement. 
Several rounds of electron and difference density map inspection, model 
manipulation and refinement led to the incorporation of solvent, chloride ions and a 
number of rotamers for selected side chains. MOLPROBITY (Chen et al., 2010) was 
used at different stages to monitor model geometry in combination with the validation 
tools provided in COOT. Crystallographic statistics are presented in Table 1. 
 
3. Results and discussion 
The structure of BpLptB was determined by molecular replacement and refined to 2.4 
Å resolution. The asymmetric unit contains two polypeptide chains, which are labelled 
A and B. There was no reliable electron density for the first 12 residues in chain A, the 
 first seven and last residue in chain B and they are absent from the model. Each 
BpLptB polypeptide presents a characteristic fold resembling ATPases of other ABC 
transporter systems (Figure 1A). The asymmetric unit, a dimer, is depicted in Figure 
1B. The amino acid sequence of BpLptB is presented in Figure 2, aligned with 
sequences of four orthologues, marked up to identify characteristic features of this 
protein family. These sequences, for which structures are available, were retrieved 
from the Uniprot database ({ HYPERLINK "https://www.uniprot.org/" }) and aligned 
using T-COFFEE multiple sequence alignment (Noterdame et al., 2000). Conserved 
motifs were highlighted using Jalview (Waterhouse et al., 2009).  
The characteristic features of LptB are the Walker A and B motifs, and four 
loops involved in creating the ATPase catalytic site (Sherman et al., 2014; Figure 2). 
These six segments are highly conserved across species (Figure 2). The ATP:Mg2+ 
binding site is formed by Walker A (G-x(4)-GK-[TS]) and Walker B (hhhhDE) motifs 
(Walker et al., 1982; Hanson & Whiteheart, 2005). The Q-loop is a conformationally 
variable region located between Walker A and Walker B motifs with a conserved 
glutamine (Gln97) participating in nucleotide binding. This residue is proposed to help 
couple ATP hydrolysis to conformational changes in the TM domains of LptFG 
(Sherman et al., 2014). In addition, a characteristic signature motif or C-loop, is placed 
near the Walker B motif and also interacts with ATP. In LptB the D-loop with a 
conserved Asp186, interacts with the Walker A motif of the partner subunit  (Davidson 
et al., 2008). The H-loop, carrying a residue of functional importance, His212 is a part 
of a conformational switch region, which participates in coordination of the γ-
phosphate of ATP (Sherman et al., 2014). 
Although present in the crystallisation conditions there was no evidence in the 
electron density for either ATP or Mg2+. The absence of cofactor in the structure may 
be explained by the ionic strength of the crystallisation conditions and the fact that the 
ATP-binding site is a relatively open cleft located on the surface of the protein. Two 
chloride ions were found associated with the ATP-binding domain with one interacting 
with His212. The presence of chloride, a component of the crystallisation condition, is 
consistent with a biologically relevant site, where a negatively charged entity can bind. 
The LptB polypeptides, which display similar conformations, form a dimer of 
approximate dimensions 85 x 50 x 25 Å. The elongated structure of the BpLptB dimer 
may contribute to the observed gel-filtration data where the elution volume 
corresponded to a MW ≈ 42 kDa, intermediate between the predicted molecular weight 
 of monomer (MW ≈ 28 kDa) and dimer (MW ≈ 56 kDa). A structural overlay of 240 
Cα atoms common to the two polypeptides in the BpLptB asymmetric unit results in a 
(root-mean-square deviation) r.m.s.d. of 0.88Å. This value falls in the range of 
r.m.s.d.s noted for superposition of the two LptB polypeptides in the asymmetric unit 
of structures for four orthologues, 0.50 to 1.11 Å, for which sequences are shown in 
Figure 2. The LptB subunit fold is conserved and displays no major conformational 
differences irrespective of whether the cofactor is present in the structure or not. Cα 
superposition of individual BpLptB monomers on the subunits A and B of homologous 
structures results in an average r.m.s.d. of 1.84 Å for 16 such overlays. Structural 
comparisons of the dimeric LptB assembly indicates that these subunits interact in a 
similar fashion either in isolation or when part of the LptB2FG complex. A structural 
overlay of the BpLptB dimer with LptB polypeptides in LptB2FG complexes from 
Pseudomonas aeruginosa (Figure 3; PDB: 5X5Y; Quingshang et al., 2017) and 
Klebsiella pneumoniae (PDB: 5L75; Dong et al., 2017) provided an r.m.s.d from the 
BpLptB dimer of 1.86 Å and 2.24 Å respectively indicating that the dimeric structures 
are similar. These values are derived from the least-squared overly of 460 and 441 Cα 
positions respectively.  
Areas where two LptB subunits interact with each other involve the Walker A 
motif and D-loop and these part of the structure share a high degree of sequence 
conservation in LptB orthologs (Figure 2). Analysis of BpLptB using Pisa (Krissinel & 
Henrick, 2007) indicates that each subunit contributes approximately 6.6 % of the 
surface (around 800 Å2) to dimer formation with an estimated solvation free energy 
gain of - 6.2 ΔiG kcal/mol. For the LptB dimers forming part of LptB2FG complexes in 
P. aeruginosa and K. pneumonia these values are around 700 Å2; -3.4 ΔiG kcal/mol 
and 600 Å2; -6.3 ΔiG kcal/mol respectively. These values are low compared to the 
commonly accepted threshold where >900 Å2 lost solvent accessible surface area and 
with ΔiG <-8 kcal/mol is considered to be an indication of a dimer (Jones & Thornton, 
1996). Nevertheless, the size-exclusion chromatography profile of BpLptB and the 
consistent arrangement of subunits in crystal structures of orthologs suggest that 
BpLptB does indeed display the structure of a functional dimer. 
The structural conservation with orthologs suggests that LptB does not undergo 
any major structural changes when it forms a complex with the LptFG heterodimer. An 
overlay of the LptB components of the LptB2FG complexes from P. aeruginosa (PDB: 
 5X5Y) and the structure reported here provides a model to identify which parts of 
BpLptB might be involved in complex formation with the membrane bound 
heterodimer. The LptFG assemblies interact with LptB through placement of an α-
helix, called the “coupling helix” (Dong et al., 2017), into grooves on the LptB dimer 
that are formed by a continuous stretch of residues from Pro83 through to Arg103 in 
BpLptB. This segment of the polypeptide comprises the Q-loop and a region preceding 
it, both of which are highly conserved in LptB sequences (Figure 2). There is also a 
contribution from the C-loop. Seven residues, placed in or at the side of the LptB 
grooves and C-loop have been identified as important to formation of a functional 
LptB2FG complex (Dong et al., 2016; Sherman et al., 2014, Simpson et al., 2016). The 
overlay positions the seven residues in BpLptB at the interface with LptF and LptG. In 
BpLptB these residues correspond to His85, Ser89, Tyr94, Phe102, Arg103, Val114, 
and Arg161. These residues are highlighted in Figure 2. Five of the residues are strictly 
conserved in the five sequences shown, Val114 is conserved in four of them with an 
isoleucine observed in one. Ser89 is substituted with arginine in three of the sequences. 
This strictly conserved phenylalanine, Phe102, is essential for interaction with the 
cognate-binding partners (Sherman et al., 2014; Simpson et al., 2016). It is of note also 
that the antibiotic novobiocin binds E. coli LptB to activate the LPS transporter 
system, by directly interacting at the Phe102-Arg103 site (May et al., 2017).  
Pairwise alignments of five sequences that create LptFG heteromers were 
carried out. The sequences were derived from the species listed in Figure 2. The 
sequence identity for LptF pairs ranged from 27 to 85%, for LptG from 26 to 93%. A 
key aspect of LptFG interactions with LptB involves a serine glutamate dipeptide unit, 
in a helical conformation on the N-terminal segment of the former (Dong et al., 2017). 
This dipeptide is strictly conserved in all LptF and LptG sequences. Our observations 
support the conclusion that the protein-protein interactions that create a stable 
LptB2FG complex are maintained across species (Dong et al., 2017). The targeted 
disruption of this protein-protein interface might then interfere with lipid A transport 
from the IM to the OM and in so doing compromise the viability of a wide range of 
gram-negative pathogens.   
 
4. Concluding remarks 
 A robust and reproducible protocol for recombinant protein production of BpLptB in 
E. coli has been established, protein purified, crystallisation conditions established and 
the crystal structure determined at 2.4 Å resolution. Comparison of BpLptB to its 
orthologs, characterised individually or in the form of LptB2FG complexes indicates 
that the molecular features responsible for the LptB-LptB interactions and associations 
with LptFG appear widely conserved. Disruption of the relevant protein-protein 
assemblies by targeting the relevant interfacial regions offers opportunities to develop 
novel antibiotics.  
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 Table 1. Crystallographic statistics for BpLptB. 
Resolution range (Å)  
Space Group 
63.7 - 2.4 
P 21 21 21 
Unit cell parameters a=52.79 b= 74.23,  
c= 124.38 Å 
Wavelength (Å) 0.9686 
No. Reflections a 71991 (7291) 
No. Unique Reflections 19107 (1977) 
Rmerge b 0.119 (0.703) 
Rpim c 0.082 (0.496) 
Completeness (%) 97.0 (98.0) 
‹I/σ(I)› 10.2 (5.8) 
Multiplicity  3.8 (3.7) 
CC1/2 0.982 (0.487) 
Mosaicity (°) 0.32 
Wilson B-factor (Å2) 22.5 
Rwork d (%) 0.205 
Rfree e (%) 0.270 
R.m.s.d bonds (Å) 0.0085 
R.m.s.d angles (°) 1.2528 
Total protein residues  493 
Total protein atoms 3777 
Average protein B-factor (Å2) 29.16 
DPI (Å) f 0.6355 
Ramachandran plot:  
     Favored (%) 97 
     Allowed (%) 3 
     Outliers (%) 0 
Additional groups:  
     Solvent (No./Average B (Å2)) 113 / 26.83 
     Chloride (No./Average B (Å2)) 2 / 30.54 
a Values in parentheses refer to the highest resolution shell. b Rmerge = ∑h∑i||(h,i) - <I(h)> ∑h∑i I(h,i); where I(h,i) is 
the intensity of the ith measurement of reflection h and <I(h)> is the mean value of I(h,i) for all i measurements. c 
Rpim  is the same as Rmerge but independent of redundancy. d Rwork = ∑hkl||Fo|-|Fc||/∑|Fo|, where Fo is the observed 
structure factor amplitude and the Fc is the structure-factor amplitude calculated from the model. e Rfree is the same 
as Rwork except calculated with a subset, 5%, of data that are excluded from refinement calculations. f The 
Diffraction-component Precision Index as defined by Cruickshank, 1999. 
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Figure 1. A. A Cα trace of BpLptB subunit A. The characteristic motifs of this protein 
family are colored blue and labelled. B. A van der Waals surface representation of the 
BpLptB dimer. Subunit A is colored light grey, subunit B yellow. The groves between 
Pro83 and Arg103 where proposed interactions with BpLptFG take place are shown in 
dark grey. The position of two residues that are highly conserved across LptB 










Figure 2. Sequence comparison of five LptB orthologs for which structures are known. 
B. pseudomallei (this work), B. phymatum (PDB: 4WBS; 90% sequence identity), E. 
coli (PDB: 4P31; 59% sequence identity), K. pneumonia (PDB: 5L75; 58% sequence 
identity), and P. aeruginosa (PDB: 5X5Y; 56% sequence identity). Sequences are 
aligned and coloured by conservation using an 80% identity threshold. Conserved and 
functionally important regions are labelled and the seven residues implicated in 
complex formation with LptFG are marked with a red star. 
   
  
 
Figure 3. A Cα overlay of the BpLptB dimer with LptB polypeptides in LptB2FG 
complexes from P. aeruginosa. BpLptB subunits A and B are coloured in black and 
blue respectively. P. aeruginosa LptB is shown in red.   
Figure 3. 
